Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer

Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer

Introduction: Limited-stage small-cell lung cancer (LS-SCLC) is potentially curable with concurrent chemoradiation (CRT). Cisplatin is the preferred platinum for the chemotherapy backbone in national guidelines. Unfortunately, many LS-SCLC patients are elderly, with comorbidities and poor performanc...

Full description

Bibliographic Details
Main Authors: Shashank Sama, Kathleen Kerrigan, Jennifer A. Sinnott, Sonam Puri, Wallace Akerley, Benjamin Haaland, Shiven Patel
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Real-world outcomes
Chemoradiation
Platinum therapy
Retrospective analysis
Radiosensitizer
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294223000072

Internet

http://www.sciencedirect.com/science/article/pii/S2468294223000072

Similar Items